Literature DB >> 21948366

Granzyme B: a new crossroad of complement and apoptosis.

Mario Perl1, Stephanie Denk, Miriam Kalbitz, Markus Huber-Lang.   

Abstract

In response to severe tissue trauma, several "molecular danger" sensing and signaling pathways are activated, especially the complement and the apoptosis cascade. Although possible crossroads between both systems have been proposed, little is known about the underlying molecular interactions. In this study a new interaction interface is presented for C3a and C5a generation by the pro-apoptotic factor granzyme B. In vitro incubation of the central human complement components C3 and C5 with the serine protease granzyme B resulted in a concentration-dependent production of the anaphylatoxins C3a and C5a. The so generated anaphylatoxin C5a was chemotactic active for isolated human neutrophils. In a translational approach, intracellular granzyme B concentration in leukocytes was determined early after severe tissue trauma. In comparison to healthy volunteers, multiple injured patients (less than one hour after trauma, Injury Severity Score > 18, n = 5) presented a significant increase in granzmye B levels in neutrophils and lymphocytes. Thus, tissue trauma is associated with early activation of both, the complement and apoptosis system. The present data suggest a new form of interaction between the complement and the apoptosis system on the level of granzyme B that is capable to generate C3a and C5a independently of the established complement proteases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21948366     DOI: 10.1007/978-1-4614-0106-3_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  The influence of coagulation and inflammation research on the improvement of polytrauma care.

Authors:  M Perl; M Huber-Lang; F Gebhard
Journal:  Eur J Trauma Emerg Surg       Date:  2011-11-09       Impact factor: 3.693

2.  T-cell development of resistance to apoptosis is driven by a metabolic shift in carbon source and altered activation of death pathways.

Authors:  C D Bortner; A B Scoltock; D W Cain; J A Cidlowski
Journal:  Cell Death Differ       Date:  2015-12-11       Impact factor: 15.828

Review 3.  The "ins and outs" of complement-driven immune responses.

Authors:  Simon Freeley; Claudia Kemper; Gaëlle Le Friec
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 4.  Complement activation in the injured central nervous system: another dual-edged sword?

Authors:  Faith H Brennan; Aileen J Anderson; Stephen M Taylor; Trent M Woodruff; Marc J Ruitenberg
Journal:  J Neuroinflammation       Date:  2012-06-21       Impact factor: 8.322

Review 5.  How apoptotic cells aid in the removal of their own cold dead bodies.

Authors:  G Wickman; L Julian; M F Olson
Journal:  Cell Death Differ       Date:  2012-03-16       Impact factor: 15.828

Review 6.  Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Authors:  Markus Huber-Lang; Kristina N Ekdahl; Rebecca Wiegner; Karin Fromell; Bo Nilsson
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

Review 7.  Complement in Pancreatic Disease-Perpetrator or Savior?

Authors:  Lucas Bettac; Stephanie Denk; Thomas Seufferlein; Markus Huber-Lang
Journal:  Front Immunol       Date:  2017-01-17       Impact factor: 7.561

Review 8.  Complement--tapping into new sites and effector systems.

Authors:  Martin Kolev; Gaelle Le Friec; Claudia Kemper
Journal:  Nat Rev Immunol       Date:  2014-11-14       Impact factor: 53.106

Review 9.  Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis.

Authors:  Marco Mannes; Christoph Q Schmidt; Bo Nilsson; Kristina N Ekdahl; Markus Huber-Lang
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

10.  X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.

Authors:  M K Evans; S J Sauer; S Nath; T J Robinson; M A Morse; G R Devi
Journal:  Cell Death Dis       Date:  2016-01-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.